Gapping up
In reaction to earnings/guidance:
- WWD +16.1%, SIBN +10.6%, SFM +10.2%, UBER +8.1%, HSBC +5.8%, FLS +5.2%, PDM +5%, NXPI +4.7%, TEX +4.6%, AER +4.4%, ZI +3.6%, ZBH +3.4%, HWM +3.1%, AMRC +2.8%, OTTR +2.7%, GPK +2.7%, ESAB +2.6%, VNOM +2.2%, LOGI +2.1%, MSTR +2%, LEG +2%, CRC +2%, KNSA +1.9%, LSCC +1.8%, ETRN +1.8%, INVH +1.7%, SAGE +1.7%, DEA +1.6%, STNG +1.6%, LNG +1.6%, TMDX +1.5%, AME +1.5%, MAR +1.5%, CEIX +1.4%, PEG +1.3%, HRMY +1.3%, QSR +1.2%, PFE +1.2%, ARLP +1%, TROW +0.9%, TAP +0.9%, CMI +0.9%, AIRC +0.8%, ABC +0.8%
Other news:
- IMTX +27.7% (announces an interim clinical data update for 11 patients with recurrent and/or refractory solid cancers treated with ACTengine IMA203 TCR-T monotherapy in the ongoing Phase 1b dose expansion Cohort A)
- APYX +8.1% (receives clearance from the U.S. FDA for the use of its APR Handpiece in procedures for coagulation of soft tissues following liposuction)
- STAG +7.3% (replacing AXON in MidCap 400)
- BB +6.4% (considering strategic alternatives for its businesses)
- BOC +2.9% (increases ownership to 100% in 24th Street Asset Management)
- CIFR +1.9% (announces April 2023 production)
- WTRG +1.6% (subsidiary acquires wastewater system)
- EDIT +1.6% (study of SLEEK published)
Analyst comments:
- VSEC +4.9% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)
- PENN +3.1% (upgraded to Buy from Neutral at ROTH MKM)
- DELL +2.9% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- HPQ +1.5% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- NLY +1.1% (upgraded to Overweight from Neutral at Piper Sandler)
